• Plk1-Dependent Regulation of p31comet in Mitotic Checkpoint

  2026-07-15

  This study elucidates how Polo-like kinase 1 (Plk1) regulates the activity of p31comet in the disassembly of mitotic checkpoint complexes, a critical process for accurate chromosome segregation. The findings clarify the phosphorylation-dependent inhibition of p31comet, providing new mechanistic insights into mitotic progression and checkpoint fidelity.

• Neomycin Sulfate: Advanced RNA/DNA & Ion Channel Workflows

  2026-07-15

  Neomycin sulfate from APExBIO empowers precise control in nucleic acid structure research and ion channel studies. Discover stepwise workflows, protocol optimizations, and troubleshooting guidance that give researchers a reproducible edge in applied molecular assays.

• Temafloxacin: Fluoroquinolone Antibacterial Agent for Resear

  2026-07-14

  Temafloxacin sets itself apart as a fluoroquinolone broad-spectrum antibacterial agent with high oral bioavailability and exceptional tissue penetration, making it a gold-standard tool for in vitro and in vivo infection models. Its robust inhibition of DNA gyrase and topoisomerase IV, plus low MIC values against difficult pathogens, empower respiratory and intracellular infection research.

• Levofloxacin: Applied Workflows in Bacterial & Bone Research

  2026-07-14

  Levofloxacin, a synthetic fluoroquinolone antibiotic, bridges antimicrobial mechanism studies and bone cell research with unique precision. This article provides actionable workflows, protocol optimizations, and troubleshooting strategies to harness Levofloxacin in both multidrug resistance and osteoblast/chondrocyte assays.

• Sisomicin vs. Tobramycin: In Vitro Activity Against Clinical

  2026-07-13

  The referenced study systematically compared sisomicin, a new aminoglycoside antibiotic, to established agents like tobramycin and gentamicin against a broad panel of clinical bacterial isolates. Findings revealed sisomicin's comparable or superior in vitro potency, while also highlighting key resistance and toxicity considerations relevant to antibiotic research.

• Cefoperazone Sodium Salt: Assay Precision and Biliary Target

  2026-07-13

  Explore the scientific underpinnings of Cefoperazone sodium salt as a β-lactamase-stable cephalosporin for advanced antibacterial assays and biliary tract infection models. This article delivers actionable insights for researchers seeking mechanistic clarity and optimized protocols.

• Vancomycin in Mechanistic MRSA Research: Beyond Comparator R

  2026-07-12

  Explore Vancomycin, a glycopeptide antibiotic, as an advanced tool for dissecting bacterial resistance mechanisms and MRSA research. This in-depth review highlights mechanistic insights, protocol strategies, and actionable lessons from landmark comparative studies.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-07-10

  The reference study uncovers a METTL16-SENP3-LTF signaling axis that enables hepatocellular carcinoma (HCC) cells to evade ferroptosis, a type of iron-dependent cell death. This mechanistic insight highlights new molecular targets to sensitize tumors to ferroptotic therapies and informs future research on iron metabolism and cancer.

• Levofloxacin in Bench Research: Applied Protocols & Optimiza

  2026-07-09

  Levofloxacin, a synthetic fluoroquinolone antibiotic, empowers both antibacterial and bone metabolism research with precision and reproducibility. This article demystifies advanced workflows, experimental pitfalls, and practical troubleshooting for researchers leveraging APExBIO's Levofloxacin in cutting-edge laboratory assays.

• Fangchinoline Restores Lysosomal Biogenesis to Block H1N1 En

  2026-07-09

  Cheng et al. demonstrate that fangchinoline restores TFEB-driven lysosomal biogenesis, effectively impeding H1N1 influenza entry by counteracting viral subversion of host degradation pathways. These findings highlight the therapeutic potential of modulating lysosomal function for antiviral intervention.

• Tacalcitol Monohydrate: A Precision Vitamin D3 Analog for On

  2026-07-08

  Explore how Tacalcitol monohydrate, a synthetic analog of vitamin D3, reshapes colorectal cancer research by enhancing 5-fluorouracil efficacy and minimizing calcemic toxicity. This article delivers an advanced, evidence-based analysis for scientists seeking targeted, translational solutions.

• Lovastatin: Applied Workflows and Troubleshooting in Cancer

  2026-07-08

  Lovastatin stands out as a robust HMG-CoA reductase inhibitor, enabling researchers to dissect cholesterol biosynthesis, apoptosis induction, and cell proliferation in both metabolic and oncology models. This guide delivers stepwise protocols, advanced assay applications, and actionable troubleshooting—drawing on recent insights and rigorous literature.

• Neomycin Sulfate: Next-Gen Probe for Triplex DNA and Ion Cha

  2026-07-07

  Discover the advanced scientific roles of Neomycin sulfate, a unique aminoglycoside antibiotic, in stabilizing DNA triplexes and modulating ryanodine receptor channels. This in-depth article offers fresh mechanistic insights and practical assay guidance not found in typical product overviews.

• Antimelanoma Actions of Phenothiazines in COLO829 and C32 Ce

  2026-07-07

  This study investigates the anticancer effects of perphenazine and prochlorperazine, two phenothiazine derivatives, on human melanotic (COLO829) and amelanotic (C32) melanoma cell lines. By elucidating their impact on cell viability, motility, and key melanogenic regulators, the research highlights potential repositioning of these agents in melanoma therapy.

• Trilaurin (Glycerol Tridodecanoate) in Lipid Nanoparticle Wo

  2026-07-06

  Trilaurin empowers precise, reproducible lipid nanoparticle and solid lipid microparticle protocols for pharmaceutical and biocatalytic applications. Its unique properties as a lipid excipient enable advanced oral delivery and targeted therapy systems, with data-driven advantages in both yield and stability.

15115 records 1/1008 page Next 12345 下5页 Last page